Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (Diluted Average): 2022-2025

Historic Shares Outstanding (Diluted Average) for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Sep 2025 value amounting to $32.0 million.

  • Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) rose 133.58% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 133.58%. This contributed to the annual value of $13.1 million for FY2024, which is 70.84% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Shares Outstanding (Diluted Average) of $32.0 million as of Q3 2025, which was up 0.03% from $32.0 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) ranged from a high of $92.2 million in Q1 2022 and a low of $5,652 during Q2 2022.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $15.2 million, with a median of $12.9 million in 2024.
  • Over the last 5 years, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) had its largest YoY gain of 143,035.17% in 2023, and its largest YoY loss of 93.54% in 2023.
  • Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) (Quarterly) stood at $5.5 million in 2022, then surged by 38.10% to $7.7 million in 2023, then soared by 70.84% to $13.1 million in 2024, then skyrocketed by 133.58% to $32.0 million in 2025.
  • Its last three reported values are $32.0 million in Q3 2025, $32.0 million for Q2 2025, and $25.7 million during Q1 2025.